LABCORP HOLDINGS INC.
LH
83 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 18 12:10 PM | Kerrii B AndersonDirector | Sale | 3,000 | $318.02 | $954.1K | 6,563(D) | View → |
| Aug 17, 2026 | Aug 17 8:31 PM | KERRII B ANDERSON | Proposed Sale | 3,000 | $318.13 | $954.4K | — | View → |
| Aug 11, 2026 | Aug 12 6:31 PM | Adam H SchechterDirector, President & CEO | Sale | 4,669 | $320.37 | $1.5M | 102,565(D) | View → |
| Aug 11, 2026 | Aug 11 2:06 PM | Schechter Adam H | Proposed Sale | 4,669 | $320.37 | $1.5M | — | View → |
| Aug 4, 2026 | Aug 6 12:26 PM | Amy B. SummyEVP, Chief Marketing Officer | Sale | 924 | $306.74 | $283.4K | 6,955.5(D) | View → |
| Aug 3, 2026 | Aug 5 3:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 1,420 | $309.23 | $439.1K | 1,770.219(D) | View → |
| Aug 4, 2026 | Aug 4 3:58 PM | Summy Amy B. | Proposed Sale | 924 | $306.74 | $283.4K | — | View → |
| Jul 2, 2026 | Jul 6 1:37 PM | Kathryn W KyleEVP, Chief Legal Officer | Sale | 92 | $286.19 | $26.3K | 3,904.457(D) | View → |
| Jul 2, 2026 | Jul 6 1:36 PM | Bryan T VaughnEVP and President, Diagnostics | Sale | 234 | $286.19 | $67.0K | 6,745.57(D) | View → |
| Jul 2, 2026 | Jul 2 4:19 PM | Kyle Kathryn W | Proposed Sale | 92 | $286.19 | $26.3K | — | View → |
| Jul 2, 2026 | Jul 2 2:29 PM | Vaughn Bryan T | Proposed Sale | 234 | $286.19 | $67.0K | — | View → |
| Jul 1, 2026 | Jul 1 2:03 PM | van der Vaart Sandra D | Proposed Sale | 7,138 | $280.48 | $2.0M | — | View → |
| Jun 8, 2026 | Jun 10 1:01 PM | Kathryn W KyleEVP, Chief Legal Officer | Sale | 762 | $263.89 | $201.1K | 3,813.457(D) | View → |
| Jun 8, 2026 | Jun 8 4:19 PM | Kyle Kathryn W | Proposed Sale | 762 | $263.89 | $201.1K | — | View → |
| May 11, 2026 | May 13 1:30 PM | Adam H SchechterDirector, President & CEO | Sale | 5,903 | $254.50 | $1.5M | 107,234(D) | View → |
| May 11, 2026 | May 11 1:51 PM | Schechter Adam H | Proposed Sale | 5,903 | $254.50 | $1.5M | — | View → |
| May 6, 2026 | May 6 2:40 PM | van der Vaart Sandra D | Proposed Sale | 6,238 | $256.76 | $1.6M | — | View → |
| Mar 27, 2026 | Mar 30 4:54 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 1,633 | $267.05 | $436.1K | 1,852.219(D) | View → |
| Mar 27, 2026 | Mar 30 4:44 PM | Jonathan C MeltzerEVP, Operations | Sale | 839 | $267.05 | $224.1K | 3,620.326(D) | View → |
| Mar 27, 2026 | Mar 27 2:40 PM | Meltzer Jonathan C | Proposed Sale | 839 | $267.05 | $224.1K | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 3 12:21 PM | Akinbolade OyegunwaEVP, CIO & CTO | Grant/Award | 750 | — | 2,940(D) | View → |
| Sep 1, 2026 | Sep 3 12:19 PM | Jonathan C MeltzerEVP, COO | Grant/Award | 900 | — | 3,594(D) | View → |
| Sep 1, 2026 | Sep 3 12:18 PM | Bryan T VaughnEVP and President, Diagnostics | Grant/Award | 1,500 | — | 5,204(D) | View → |
| Sep 1, 2026 | Sep 3 12:07 PM | Brian J CaveneyEVP, Pres of BLS, CMO & CSO | Grant/Award | 3,000 | — | 7,170(D) | View → |
| Aug 3, 2026 | Aug 5 3:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 1,338 | $209.25 | 0(D) | View → |
| Jul 1, 2026 | Jul 6 1:37 PM | Kathryn W KyleEVP, Chief Legal Officer | Option Exercise | 256 | — | 2,008(D) | View → |
| Jul 1, 2026 | Jul 6 1:36 PM | Bryan T VaughnEVP and President, Diagnostics | Option Exercise | 327 | — | 3,704(D) | View → |
| Feb 11, 2026 | Feb 13 6:19 PM | Amy B. SummyEVP, Chief Marketing Officer | Option Exercise | 230 | — | 1,304(D) | View → |
| Feb 11, 2026 | Feb 13 6:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 696 | — | 1,968(D) | View → |
| Feb 11, 2026 | Feb 13 6:16 PM | Julia Aijun WangChief Financial Officer, EVP | Option Exercise | 860 | — | 4,964(D) | View → |
| Feb 11, 2026 | Feb 13 6:15 PM | Bryan T VaughnEVP, Diagnostics | Option Exercise | 323 | — | 4,031(D) | View → |
| Feb 11, 2026 | Feb 13 6:14 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Option Exercise | 376 | — | 1,141(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Mark S SchroederEVP, Pres Diagnostics & COO | Option Exercise | 806 | — | 2,358(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Adam H SchechterDirector, President & CEO | Option Exercise | 3,656 | — | 22,214(D) | View → |
| Feb 11, 2026 | Feb 13 6:12 PM | Akinbolade OyegunwaEVP, CIO & CTO | Option Exercise | 230 | — | 2,190(D) | View → |
| Feb 11, 2026 | Feb 13 6:11 PM | Jonathan C MeltzerEVP, Operations | Option Exercise | 243 | — | 2,694(D) | View → |
| Feb 11, 2026 | Feb 13 6:10 PM | Kathryn W KyleEVP, Chief Legal Officer | Option Exercise | 216 | — | 2,264(D) | View → |
| Feb 11, 2026 | Feb 13 6:09 PM | Anita Z GrahamEVP, CHRO | Option Exercise | 356 | — | 2,401(D) | View → |
| Feb 11, 2026 | Feb 13 6:08 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Option Exercise | 740 | — | 4,170(D) | View → |
| Feb 11, 2026 | Feb 13 6:07 PM | Megan D. BaileyEVP, Pres, Central Labs & Intl | Option Exercise | 403 | — | 2,827(D) | View → |
Page 1 of 4
Next →